Language of Resource
Full Text Available
Open Access / OK to Reproduce
This article examines how clinics’ take-home dosing policies have affected patients’ experiences of treatment and lives in general.
Nearly all of the patients with past or present MMT use were highly critical of the limited access to take-home doses and consequent need for daily or near daily clinic attendance. Participants described how the use of restrictive take-home dose policies negatively impacted their ability to meet day-to-day responsibilities and also cited the need for daily attendance as a reason for quitting or avoiding OAT. Responses also demonstrate how such policies contribute to an environment of cruelty and stigma within many clinics that exposes this already-stigmatized population to additional trauma.
Semi-structured qualitative interviews (n=36)